The Development of the Visual Screening Tool for Anxiety Disorders and Depression: Addressing Barriers to Screening for Depression and Anxiety Disorders in Hypertension And/or Diabetes

Overview

Journal Afr J Prim Health Care Fam Med

Specialty Public Health

Date 2018 Jun 27

PMID 29943612

Authors

Zimbini Ogle

Liezl Koen

Dana J H Niehaus

Affiliations

Soon will be listed here.

Abstract

There is a lack of screening tools for common mental disorders that can be applied across cultures, languages and levels of education in people with diabetes and hypertension. Aim: To develop a visual screening tool for depression and anxiety disorders that is applicable across cultures and levels of education. Setting: Participants were purposively recruited from two not-for-profit organisations and two public health facilities - a maternal mental health unit and a primary health care centre. Method: This was a qualitative cross-sectional study. Thirteen drawings based on the Hospital Anxiety and Depression Scale depicting symptoms of anxiety disorders and depression were drawn. Participants described emotions and thoughts depicted in the drawings. Data were analysed through content analysis. Results: Thirty-one women (66%) and 16 men (34%) participated in the development of the visual screening tool. The mean age was 34 (standard deviation [SD] 12.46). There were 32 (68%) black participants, 11 (23%) mixed race participants and 4 (9%) white participants. Two participants (4%) had no schooling, 14 (31%) primary schooling, 8 (18%) senior schooling, 13 (29%) matric qualification and 8 (18%) had post-matric qualification. Participants correctly described 10 out of the 13 visual depiction of symptoms as associated with depression and anxiety disorders, with no differences between levels of education and cultural groups. Conclusion: Ten drawings were appropriate for inclusion in the visual screening tool for anxiety disorders and depression (VISTAD). The VISTAD will be validated against the mini international neuropsychiatric interview (MINI) in a primary care population with hypertension and/or diabetes.

References

Lecrubier Y . The burden of depression and anxiety in general medicine. J Clin Psychiatry. 2002; 62 Suppl 8:4-9; discussion 10-1. View

Roy T, Lloyd C . Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012; 142 Suppl:S8-21. DOI: 10.1016/S0165-0327(12)70004-6. View

Stein D, Aguilar-Gaxiola S, Alonso J, Bruffaerts R, de Jonge P, Liu Z . Associations between mental disorders and subsequent onset of hypertension. Gen Hosp Psychiatry. 2013; 36(2):142-9. PMC: 3996437. DOI: 10.1016/j.genhosppsych.2013.11.002. View

Petersen I, Lund C . Mental health service delivery in South Africa from 2000 to 2010: one step forward, one step back. S Afr Med J. 2012; 101(10):751-7. View

Kerr L, Kerr Jr L . Screening tools for depression in primary care: the effects of culture, gender, and somatic symptoms on the detection of depression. West J Med. 2001; 175(5):349-52. PMC: 1071624. DOI: 10.1136/ewjm.175.5.349. View

Hermanns N, Caputo S, Dzida G, Khunti K, Meneghini L, Snoek F . Screening, evaluation and management of depression in people with diabetes in primary care. Prim Care Diabetes. 2013; 7(1):1-10. DOI: 10.1016/j.pcd.2012.11.002. View

Lotfi L, Flyckt L, Krakau I, Martensson B, Nilsson G . Undetected depression in primary healthcare: occurrence, severity and co-morbidity in a two-stage procedure of opportunistic screening. Nord J Psychiatry. 2010; 64(6):421-7. DOI: 10.3109/08039481003786378. View

Mash B, Levitt N, Steyn K, Zwarenstein M, Rollnick S . Effectiveness of a group diabetes education programme in underserved communities in South Africa: pragmatic cluster randomized control trial. BMC Fam Pract. 2012; 13:126. PMC: 3560091. DOI: 10.1186/1471-2296-13-126. View

Aronow E, Reznikoff M, Moreland K . The Rorschach: projective technique or psychometric test?. J Pers Assess. 1995; 64(2):213-28. DOI: 10.1207/s15327752jpa6402_1. View

10.

Goldney R, Phillips P, Fisher L, Wilson D . Diabetes, depression, and quality of life: a population study. Diabetes Care. 2004; 27(5):1066-70. DOI: 10.2337/diacare.27.5.1066. View

11.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

12.

Egede L, Ellis C . Diabetes and depression: global perspectives. Diabetes Res Clin Pract. 2010; 87(3):302-12. DOI: 10.1016/j.diabres.2010.01.024. View

13.

Chou S, Huang B, Goldstein R, Grant B . Temporal associations between physical illnesses and mental disorders--results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Compr Psychiatry. 2013; 54(6):627-38. PMC: 3931424. DOI: 10.1016/j.comppsych.2012.12.020. View

14.

Jenkins R, Othieno C, Okeyo S, Kaseje D, Aruwa J, Oyugi H . Short structured general mental health in service training programme in Kenya improves patient health and social outcomes but not detection of mental health problems - a pragmatic cluster randomised controlled trial. Int J Ment Health Syst. 2013; 7(1):25. PMC: 4174904. DOI: 10.1186/1752-4458-7-25. View

15.

Akena D, Joska J, Musisi S, Stein D . Sensitivity and specificity of a visual depression screening instrument among HIV-positive individuals in Uganda, an area with low literacy. AIDS Behav. 2012; 16(8):2399-406. DOI: 10.1007/s10461-012-0267-1. View

16.

Hutter N, Schnurr A, Baumeister H . Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review. Diabetologia. 2010; 53(12):2470-9. DOI: 10.1007/s00125-010-1873-y. View

17.

Berge L, Riise T, Tell G, Iversen M, Ostbye T, Lund A . Depression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study. PLoS One. 2015; 10(5):e0127161. PMC: 4444007. DOI: 10.1371/journal.pone.0127161. View

18.

Andersen L, Grimsrud A, Myer L, Williams D, Stein D, Seedat S . The psychometric properties of the K10 and K6 scales in screening for mood and anxiety disorders in the South African Stress and Health study. Int J Methods Psychiatr Res. 2011; 20(4):215-23. PMC: 6878543. DOI: 10.1002/mpr.351. View

19.

Semenkovich K, Brown M, Svrakic D, Lustman P . Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015; 75(6):577-87. DOI: 10.1007/s40265-015-0347-4. View

20.

Reddy P, Philpot B, Ford D, Dunbar J . Identification of depression in diabetes: the efficacy of PHQ-9 and HADS-D. Br J Gen Pract. 2010; 60(575):e239-45. PMC: 2880765. DOI: 10.3399/bjgp10X502128. View